Actinomycin X2

• Target:

  Apoptosis|||Antibacterial|||Antibiotic

• Related Pathways:

  Microbiology/Virology|||Apoptosis

• Bioactivity:

  Actinomycin X2 (Actinomycin V) is a compound synthesized by various species of Streptomyces. It displays potent inhibition against methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 0.25 ?g/mL. Actinomycin X2 possesses potential applications in the treatment of both cancer and bacterial infections.

• Smiles:

  [H][C@@]12CCCN1C(=O)C(NC(=O)[C@@H](NC(=O)c1ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)N[C@H]5[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]6([H])CC(=O)CN6C(=O)C(NC5=O)C(C)C)c4nc13)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C

• Molecular Formula:

  C62H84N12O17

• Molecular Weight:

  1269.421

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  18865-48-0